Escitalopram oxalate and Emotional distress - a phase IV clinical study of FDA data
Emotional distress is found among people who take Escitalopram oxalate, especially for people who are female, 50-59 old, have been taking the drug for < 1 month.
The phase IV clinical study analyzes which people take Escitalopram oxalate and have Emotional distress. It is created by eHealthMe based on reports of 13,388 people who have side effects when taking Escitalopram oxalate from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
13,388 people reported to have side effects when taking Escitalopram oxalate.
Among them, 66 people (0.49%) have Emotional distress.
What is Escitalopram oxalate?
Escitalopram oxalate has active ingredients of escitalopram oxalate. It is often used in depression. eHealthMe is studying from 13,805 Escitalopram oxalate users for its effectiveness, alternative drugs and more.
What is Emotional distress?
Emotional distress is found to be associated with 2,639 drugs and 1,924 conditions by eHealthMe.
Number of Escitalopram oxalate and Emotional distress reports submitted per year:
Time on Escitalopram oxalate when people have Emotional distress *:
- < 1 month: 33.33 %
- 1 - 6 months: 33.33 %
- 6 - 12 months: 25.0 %
- 1 - 2 years: 8.33 %
- 2 - 5 years: 0.0 %
- 5 - 10 years: 0.0 %
- 10+ years: 0.0 %
Gender of people who have Emotional distress when taking Escitalopram oxalate *:
- female: 57.81 %
- male: 42.19 %
Age of people who have Emotional distress when taking Escitalopram oxalate *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 2.22 %
- 20-29: 6.67 %
- 30-39: 6.67 %
- 40-49: 22.22 %
- 50-59: 35.56 %
- 60+: 26.67 %
Common drugs people take besides Escitalopram oxalate *:
- Isentress: 15 people, 22.73%
- Lexapro: 12 people, 18.18%
- Truvada: 12 people, 18.18%
- Hydroxyzine: 11 people, 16.67%
- Atripla: 10 people, 15.15%
- Wellbutrin: 10 people, 15.15%
- Epivir: 9 people, 13.64%
- Crestor: 9 people, 13.64%
- Sandostatin: 9 people, 13.64%
- Sulfamethoxazole And Trimethoprim: 8 people, 12.12%
Common side effects people have besides Emotional distress *:
- Anhedonia (inability to experience pleasure from activities usually found enjoyable): 25 people, 37.88%
- Fatigue (feeling of tiredness): 25 people, 37.88%
- Pain: 23 people, 34.85%
- Weakness: 17 people, 25.76%
- Suicidal Ideation: 17 people, 25.76%
- Nausea (feeling of having an urge to vomit): 16 people, 24.24%
- Mental Disorder (a psychological term for a mental or behavioural pattern or anomaly that causes distress or disability): 16 people, 24.24%
- Diarrhea: 15 people, 22.73%
- Chronic Kidney Disease: 15 people, 22.73%
- Pain In Extremity: 14 people, 21.21%
Common conditions people have *:
- Hiv Infection: 19 people, 28.79%
- Pain: 12 people, 18.18%
- Neuroendocrine Tumor: 10 people, 15.15%
- High Blood Pressure: 8 people, 12.12%
- Insomnia (sleeplessness): 7 people, 10.61%
- Major Depression (a mood state that goes well beyond temporarily feeling sad or blue. it is a serious medical illness that affects one's thoughts, feelings): 6 people, 9.09%
- Affective Disorder (mental disorder): 6 people, 9.09%
- Asthma: 6 people, 9.09%
- Iron Deficiency: 6 people, 9.09%
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 6 people, 9.09%
* Approximation only. Some reports may have incomplete information.
Do you take Escitalopram oxalate and have Emotional distress?Check whether Emotional distress is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- O’Brien FE, O’Connor RM, Clarke G, Donovan MD, Dinan TG, Griffin BT, Cryan JF, "The P-glycoprotein inhibitor cyclosporin A differentially influences behavioural and neurochemical responses to the antidepressant escitalopram", Behavioural brain research, 2014 Mar .
How severe was Emotional distress and when was it recovered:
Expand to all the drugs that have ingredients of escitalopram oxalate:
Alternative drugs to, pros and cons of Escitalopram oxalate:
- Escitalopram oxalate (13,805 reports)
Common Escitalopram oxalate side effects:
Browse all side effects of Escitalopram oxalate:a b c d e f g h i j k l m n o p q r s t u v w x y z
Emotional distress treatments and more:
- Emotional distress (148,478 reports)
COVID vaccines that are related to Emotional distress:
- Emotional distress in Moderna COVID Vaccine
- Emotional distress in Pfizer BioNTech Covid Vaccine
- Emotional distress in Johnson and Johnson Covid Vaccine
Common drugs associated with Emotional distress:
All the drugs that are associated with Emotional distress:
- Emotional distress (2,639 drugs)
Common conditions associated with Emotional distress:
All the conditions that are associated with Emotional distress:
- Emotional distress (1,924 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on escitalopram oxalate (the active ingredients of Escitalopram oxalate) and Escitalopram oxalate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Chlorpheniramine Maleate and Tracleer drug interaction - 10 seconds ago
- Innohep and Escitalopram drug interaction - 10 seconds ago
- Metoclopramide and Calcium Carbonate drug interaction - 11 seconds ago
- Sodium Chloride and Metronidazole drug interaction - 18 seconds ago
- Magnesium and Laevocardia - 32 seconds ago
- Bisoprolol Fumarate and Creon drug interaction - 33 seconds ago
- Intal and Withdrawal Syndrome - 41 seconds ago
- Krill Oil and Overdose - 47 seconds ago
- Beconase and Hypercalcaemia - a minute ago
- Folic Acid and Reblozyl drug interaction - a minute ago